Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).
about
MST1 promotes apoptosis through regulating Sirt1-dependent p53 deacetylationNew Therapeutic Concept of NAD Redox Balance for Cisplatin NephrotoxicityTargeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implicationsMechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer CellsCutaneous T-cell lymphoma: 2014 update on diagnosis, risk-stratification, and managementAcetylation of the pro-apoptotic factor, p53 in the hippocampus following cerebral ischemia and modulation by estrogenA Small Molecule Binding to the Coactivator CREB-Binding Protein Blocks Apoptosis in CardiomyocytesThe Role of Histone Acetyltransferases in Normal and Malignant HematopoiesisProliferating cell nuclear antigen is protected from degradation by forming a complex with MutT Homolog2Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia TherapyA phase I study of pulse high-dose vorinostat (V) plus rituximab (R), ifosphamide, carboplatin, and etoposide (ICE) in patients with relapsed lymphoma.Enhanced deacetylation of p53 by the anti-apoptotic protein HSCO in association with histone deacetylase 1.HDAC inhibitors act with 5-aza-2'-deoxycytidine to inhibit cell proliferation by suppressing removal of incorporated abases in lung cancer cells.Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors.Phase II study of vorinostat for treatment of relapsed or refractory indolent non-Hodgkin's lymphoma and mantle cell lymphomaThe role of p300 histone acetyltransferase in UV-induced histone modifications and MMP-1 gene transcriptionRUNX3 modulates DNA damage-mediated phosphorylation of tumor suppressor p53 at Ser-15 and acts as a co-activator for p53.Rapid temporal control of Foxp3 protein degradation by sirtuin-1.SAHA and S116836, a novel tyrosine kinase inhibitor, synergistically induce apoptosis in imatinib-resistant chronic myelogenous leukemia cells.Novel histone deacetylase inhibitor CG200745 induces clonogenic cell death by modulating acetylation of p53 in cancer cells.The impact of acetylation and deacetylation on the p53 pathway.HPV 5 and 8 E6 abrogate ATR activity resulting in increased persistence of UVB induced DNA damageEffects of ethylene glycol monomethyl ether and its metabolite, 2-methoxyacetic acid, on organogenesis stage mouse limbs in vitroPhase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336)Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancerGinsenoside Rg3 inhibits melanoma cell proliferation through down-regulation of histone deacetylase 3 (HDAC3) and increase of p53 acetylation.Mining differential top-k co-expression patterns from time course comparative gene expression datasetsMicroRNA and messenger RNA profiling reveals new biomarkers and mechanisms for RDX induced neurotoxicity.Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancerHistone deacetylase inhibitor valproic acid suppresses the growth and increases the androgen responsiveness of prostate cancer cells.Resveratrol Upregulates Cardiac SDF-1 in Mice with Acute Myocardial Infarction through the Deacetylation of Cardiac p53The effects of DNA methylation and histone deacetylase inhibitors on human papillomavirus early gene expression in cervical cancer, an in vitro and clinical studyCharacterization and prediction of lysine (K)-acetyl-transferase specific acetylation sites.Nonhistone protein acetylation as cancer therapy targets.Targeting Histone Deacetylases in Diseases: Where Are We?Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy.Histone deacetylase inhibition and the regulation of cell growth with particular reference to liver pathobiology.Surf the post-translational modification network of p53 regulationThe histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathwaysProposed megakaryocytic regulon of p53: the genes engaged to control cell cycle and apoptosis during megakaryocytic differentiation.
P2860
Q24324230-C8E8FC73-4955-491F-81F0-F8E5BDD7C637Q26765483-33772999-4B54-4485-A36A-D61559FCB3E4Q26853394-1CAFBB44-9E91-4CCD-BDE1-078BA9D42EEAQ27015931-A90D9BF6-F288-4219-BA28-AE234770875BQ27024076-F0F5CBA3-AC3B-4966-8D84-F0481AB6798DQ27314528-85CB1E67-63AC-4A18-BED4-36856E929C93Q27667526-15491182-FDBF-44D3-B6E7-FB2677745BC6Q28088295-DC6534B2-B5DE-46C3-811C-B5C4F661CD68Q28118092-D922973F-5A5E-4525-B9D4-76532C6D8A3CQ28269627-B23AE839-1D2F-42DD-A3E9-0038B8A39FF8Q30538453-DE793E63-C831-456C-A133-7E95FCB7A9A8Q33278013-5EC50495-E557-47DE-BC03-B658FB6F94D1Q33344484-A87F2869-21BE-493C-958F-441A5D7262CCQ33390876-8114E148-F3E2-416D-B889-A99ED27DF468Q33394023-C7D8FE35-EF82-444D-AD97-EF4BEAB58640Q33418281-28767A01-1968-4266-883D-C8FDD471DB68Q33883483-9FB7DEF0-0F76-4414-B536-5A9996A54FD1Q33886284-D74CBDA8-B2C6-40D2-9FBA-2876E88735EDQ33911230-81F89524-53FB-45AE-9D3B-80456E18A771Q34145992-54218253-3B0A-4412-8ADA-01125E174278Q34199692-6497F5A7-B147-462F-81BE-40736B1A0256Q34341388-74738230-2128-40E8-AF00-6A9366698A0DQ34488832-8256C372-A11B-40A1-A16C-DA004757ACA3Q34510205-AC4DEE51-1E11-4DCF-8502-E60CD92C7DD5Q34591131-046010D9-9007-4FCA-9D36-6F45E6B158FCQ34734168-185C09F9-5B53-4385-B38E-33925DBE0AD8Q34839841-0BE9662B-25CA-4782-8D98-F958C496D1BDQ35005163-C69F7106-8897-4755-846D-E87871310010Q35079955-4B3D8836-C76B-40CC-8ED6-5EAC2AEB816BQ35596729-31979156-13D6-4816-92E2-767D5F583A7FQ35656378-B79BA85D-2FE4-4CE0-97DF-6173A5EDC522Q35674823-255DFF4C-5FA4-4E47-8A25-E56254E86DC1Q35722270-BD79FDB8-4D1B-4D73-AF85-27A5F648BEB8Q35739676-E7A3017E-36CD-444F-9AC5-DADF042A07FDQ35821728-DECB27B0-1F35-4C89-91F0-7EABC239E4CFQ35856816-49B26C16-E80A-4870-8363-8255AC1F7C54Q35893218-FB9BEBC3-ECCC-4D48-939E-26615CC66314Q35967111-E01B0051-213D-403D-9F9D-648825232466Q36157305-E649887C-8100-4432-9220-11F4CAFBB205Q36185474-EAAB9DFD-261B-4CFB-8F30-953987C8AB8E
P2860
Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Acetylation of p53 at lysine 3 ...... tide induces expression of p21
@nl
Acetylation of p53 at lysine 3 ...... expression of p21(Waf1/Cip1).
@ast
Acetylation of p53 at lysine 3 ...... expression of p21(Waf1/Cip1).
@en
type
label
Acetylation of p53 at lysine 3 ...... tide induces expression of p21
@nl
Acetylation of p53 at lysine 3 ...... expression of p21(Waf1/Cip1).
@ast
Acetylation of p53 at lysine 3 ...... expression of p21(Waf1/Cip1).
@en
prefLabel
Acetylation of p53 at lysine 3 ...... tide induces expression of p21
@nl
Acetylation of p53 at lysine 3 ...... expression of p21(Waf1/Cip1).
@ast
Acetylation of p53 at lysine 3 ...... expression of p21(Waf1/Cip1).
@en
P2093
P2860
P1476
Acetylation of p53 at lysine 3 ...... s expression of p21(Waf1/Cip1)
@en
P2093
Gregory A Otterson
Guolin Chai
Haiying Wang
Quanhui Zheng
Yingqi Chen
P2860
P304
P356
10.1128/MCB.26.7.2782-2790.2006
P407
P577
2006-04-01T00:00:00Z